|
Age (years, mean ± SD)
|
45.00 ± 3.17
|
48.00 ± 7.05
|
46.00 ± 7.49
|
|
Men, n (%)
|
19 (70.37%)
|
20 (71.43%)
|
19 (65.52%)
|
|
History of gout (years, median (range))
|
3.00 (0–9)
|
3.00 (0–10)
|
3.00 (0–11)
|
|
BMI (kg/m2, mean ± SD)
|
32.00 ± 5.07
|
31.07 ± 4.00
|
32.05 ± 5.99
|
|
Uric acid (pre-treatment) (μmol/L, mean ± SD)
|
480.04 ± 98.04
|
470.14 ± 90.12
|
479.97 ± 97.96
|
|
Onset time, n (%)
|
|
≤ 24 h
|
3 (11.11%)
|
4 (14.29%)
|
5 (17.24%)
|
|
24–48 h
|
9 (33.33%)
|
8 (28.57%)
|
8 (27.59%)
|
|
48–72 h
|
15 (55.56%)
|
16 (57.14%)
|
16 (55.17%)
|
|
Index joint, n (%)
|
|
Metatasophalangeal joint 1
|
4 (14.81%)
|
3 (10.71%)
|
4 (13.79%)
|
|
Other foot joints,
|
5 (18.52%)
|
5 (17.86%)
|
9 (31.03%)
|
|
Ankle
|
5 (18.52%)
|
6 (21.43%)
|
7 (24.14%)
|
|
Knee
|
6 (22.22%)
|
9 (32.14%)
|
7 (24.14%)
|
|
Wrist
|
1 (3.70%)
|
1 (3.57%)
|
0
|
|
Hand
|
2 (7.41%)
|
3 (10.71%)
|
2 (6.90%)
|
|
Elbow
|
1 (3.70%)
|
0
|
0
|
|
Multiple joints
|
3 (11.11%)
|
1 (3.57%)
|
0
|
|
Joint swelling, n (%)
|
|
No swelling
|
0
|
2 (7.14%)
|
0
|
|
Palpable
|
6 (22.22%)
|
8 (28.57%)
|
8 (27.59%)
|
|
Visible
|
6 (22.22%)
|
8 (28.57%)
|
10 (34.48%)
|
|
Bulging beyond joint margins
|
15 (55.56%)
|
10 (35.71%)
|
11 (37.93%)
|
|
Activity, n (%)
|
|
No restricted
|
0
|
0
|
0
|
|
Moderate restricted
|
5 (18.52%)
|
7 (25.00%)
|
9 (31.03%)
|
|
Significantly restricted
|
9 (33.33%)
|
11 (39.29%)
|
10 (34.48%)
|
|
Unbearable, cannot take care of themselves
|
13 (48.14%)
|
10 (35.71%)
|
10 (34.48%)
|
|
Smoke use, n (%)
|
5 (18.52%)
|
7 (25.00%)
|
6 (20.69%)
|
|
Drink, n (%)
|
10 (37.04%)
|
11 (39.29%)
|
11 (37.93%)
|
